USE OF G-CSF FOR THE EXTENSION OF THE THERAPEUTIC TIME-WINDOW OF THROMBOLYTIC STROKE THERAPY

• 1. G-CSF用于延长卒中溶栓治疗的治疗时间窗的用途 [P] . 中国专利： CN102316891A . 2012-01-11
• 2. G-CSF用于治疗卒中的用途 [P] . 中国专利： CN101842108A . 2010-09-22
• 3. Use of G-CSF for the extension of the therapeutic time-window of thrombolytic stroke therapy [P] . AU2010216083A1 . 2011-08-18

  机译： 使用G-CSF延长溶栓性中风治疗的治疗时间

• 4. USE OF G-CSF FOR THE EXTENSION OF THE THERAPEUTIC TIME-WINDOW OF THROMBOLYTIC STROKE THERAPY [P] . 欧洲知识产权局专利： EP2398493A1 . 2011-12-28

  机译： 使用G-CSF延长溶栓性卒中治疗的治疗时间窗

• 5. USE OF G-CSF FOR THE EXTENSION OF THE THERAPEUTIC TIME-WINDOW OF THROMBOLYTIC STROKE THERAPY [P] . 世界知识产权组织专利： WO2010096446A1 . 2010-08-26

  机译： 使用G-CSF延长溶栓性卒中治疗的治疗时间窗

• 1. Prognostic Biomarkers in Patients with Ischemic Stroke Who Received Thrombolytic Therapy [J] . Aleksandrs Fjodorovs 药剂与药理学：英文版 . 2018,第006期
• 2. Comprehensive Management Strategies for Thrombolytics in Patients with Acute Ischemic Stroke [J] . Yuan-Qiang Lu, Da-Gan Yang, Yun-Mei Yang 脑血管病电子杂志(英文) . 2018,第001期
• 3. Outcomes of thrombolytic therapy for acute ischemic stroke in Chinese patients: the Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) study. [J] . Chao AC, Hsu HY, Chung CP, Stroke: A Journal of Cerebral Circulation . 2010,第5期
• 4. Future demographic trends decrease the proportion of ischemic stroke patients receiving thrombolytic therapy: a call to set-up therapeutic studies in the very old. [J] . Foerch C, Sitzer M, Steinmetz H, Stroke: A Journal of Cerebral Circulation . 2009,第5期
• 5. Therapeutic time window of thrombolytic therapy following stroke. [J] . Schellinger PD, Warach S Current atherosclerosis reports. . 2004,第4期
• 6. Development of a Portable Actuated Orthotic Glove to Facilitate Gross Extension of the Digits for Therapeutic Training after Stroke [C] . J. Mauricio Ochoa, Yicheng Jia, Dev Narasimhan, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2009
• 7. Engineering analysis of two new modes of therapy: Rheological incompatibility between erythrocytes and a perfluorochemical blood substitute, and kinetic aspects of intravenous thrombolytic therapy with streptokinase. [D] . Tuliani, Vinod Vashdev. 1989
• 8. Dose–response therapeutic time-window and tPA-combinatorial efficacyof compound 21: A randomized blinded preclinical trial in a rat model ofthromboembolic stroke [O] . Tauheed Ishrat, Abdelrahman Y Fouda, Bindu Pillai, 2019
• 9. Effect of mexidol on the efficiency of intravenous thrombolytic therapy for ischemic stroke during the therapeutic window [O] . K. S. Knni, T. V. Dyomin, L. B. Adeeva 2018

• 1. Efficacy and Safety of Tirofiban in Thrombolytic Therapyfor Ischemic Stroke [J] . Ruixian Wang ,Lishun Yang ,Jianhui Zhang . 临床护理研究 . 2020,第001期
• 2. Therapeutic Application of High-Frequency rTMS Combined with Intensive Occupational Therapy for Pediatric Stroke Patients with Upper Limb Hemiparesis: A Case Series Study [J] . Masachika Niimi ,Wataru Kakuda ,Toru Takekawa . 行为与脑科学期刊（英文） . 2013,第2期
• 3. New Stroke-healing Gel Helped Regrow Neurons and Blood Vessels in Mice with Stroke-damaged Brains, Hinting at What May Someday Be a New Therapy for Stroke in People [J] . . 中国生物医学工程学报：英文版 . 2018,第2期
• 4. 影响急性缺血性脑卒中溶栓治疗时间窗的因素及干预措施 [C] . 刘磊 ,孔繁军 . 中国医师协会21世纪神经科学新进展大会 . 2006
• 5. rt-PA和MCI-186联合治疗延长血栓性脑栓塞大鼠模型的治疗时间窗的研究 [A] . 吴文涛 . 2005